Skip to Content

'
Bouthaina S. Dabaja, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Section Chief of Lymphoma, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1990 Lebanese University-Faculty of Medicine, Beirut, Lebanon, MD, Medicine

Postgraduate Training

2003 Clinical Fellowship, Stereotactic 3D Conformal Fellowship, The University of Texas MD Anderson Cancer Center (Non-Accredited Participation in Program), Houston, TX
1999-2003 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1997-1999 Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1993-1996 Clinical Fellowship, Hematology, American University of Beirut-Faculty of Medicine, Beirut, Lebanon
1990-1993 Clinical Residency, Internal Medicine, American University of Beirut-Faculty of Medicine, Beirut, Lebanon

Board Certifications

6/2003 American Board of Radiology

Experience/Service

Academic Appointments

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2010

Other Appointments/Responsibilities

Member, American College of Radiology Appropriateness Criteria: Radiaition Oncology, Lymphoma Panel, 6/2012-6/2013
Panel Member, National Comprehensive Cancer Network Hodgkin's Lymphoma Panel, 2011-present
Panel Expert, International Lymphoma Radiation Oncology Group Steering Committee, Copenhagen, Denmark, 2011-present
Panel Expert, Appropriateness Criteria Expert Panel of the American College of Radiology, Reston, VA, 2011-present
Panel Expert, Radiation Oncology- Hodgkins Disease Working Group Panel, American College of Radiology, Reston, VA, 2011-2012
Oral Board Examiner, American Board of Radiology, Louisville, KY, 2010-present
Panel Expert, National Comprehensive Cancer Network, Washington, DC, 2007-present

Institutional Committee Activities

Member, T-Cell Lymphoma Group, 2009-present
Member, Hodgkin's Lymphoma Group, 2008-present
Member, The University of Texas MD Anderson Cancer Center- American University of Beirut Faculty of Medicine Steering Committee, 2007-present
Member, Clinical Effectiveness Committee, 2007-present
Member, Lymphoma Steering Committee, 2006-present

Honors and Awards

2008-2009 Teacher of the Year Award, Association of Residents in Radiation Oncology
2003 Janice Davis Singletary Award
2003 Oncology Fellows Connect Program Nominee
2002 Honorary Merit-Radiation Research Award
2001 Research Education Award, The University of Texas MD Anderson Cancer Center

Professional Memberships

American College of Radiology
Member, 6/2000-present
American Society of Clinical Oncology
Member, 6/1999-present
American Society of Hematology
Member, 6/2000-present
American Society of Radiation Oncology
Member, 6/2001-present
International Extranodal Lymphoma Study Group
Member, 6/2007-present
International Society of Lymphoma Radiation Oncology
Member, 10/2010-present
United States Cutaneous Lymphoma Consortium
Member, 12/2009-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Wang C, Duvic M, Dabaja B. Acral ulcerative mycosis fungoides: successful treatment with localized radiotherapy. BMJ Case Rep. In Press.
2. Dabaja B, Liang FW, Podoloff D, Shihadeh F, Etzel C, Medeiros LJ, Mawlawi O, Oki Y, Hagemeister FB, Fayad LE, Kadir A, Wogan CF, Rodriguez A. Mid-therapy PET scan significantly predicts outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with chemotherapy alone but not when consolidation radiation is added. J Clin Oncol. In Press.
3. Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. J Natl Compr Canc Netw 10(7):815-819, 7/2012. PMID: 22773797.
4. Batty N, Hagemeister FB, Feng L, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. Doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy with interferon for advanced stage classic hodgkin's lymphoma: a 10-year follow-up study. Leuk Lymphoma 53(5):801-806, 5/2012. PMID: 22023528.
5. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H. Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw 10(5):589-597, 5/2012. PMID: 22570290.
6. Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, Rodriguez MA, Dang N, Kwak LW, Neelapu SS, Fayad LE. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood 119(18):4123-4128, 5/2012. PMCID: PMC3359733.
7. Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer 118(1):112-117, 1/2012. PMID: 21692072.
8. Younes A, Oki Y, Copeland A, Feng L, Yuan Y, Chuang H, Macapinlac H, Fanale M, Fayad L, McLaughlin P, Pro B, Hagemeister F, Romaguera J, Samaniego F, Dabaja B, Rodriguez M. Phase II study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin's lymphoma. Blood. e-Pub 1/2012.
9. Sharp H, Grosshans D, Kadia T, Dabaja BS. Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia. BMJ Case Rep 2012, 2012. e-Pub 7/2012. PMID: 22787181.
10. Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Med Dosim 37(4):374-382, 2012. e-Pub 4/2012. PMID: 22513213.
11. Phan J, Mazloom A, Abboud M, Salehpour M, Reed V, Zreik T, Shihadeh F, Fisher C, Wogan C, Dabaja B. Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. Am J Clin Oncol 34(5):499-505, 10/2011. PMID: 21537149.
12. Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer 117(19):4468-4474, 10/2011. PMID: 21437886.
13. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J. Hodgkin lymphoma. J Natl Compr Canc Netw 9(9):1020-1058, 9/2011. PMID: 21917626.
14. Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 81(1):167-174, 9/2011. PMID: 20643518.
15. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2/2011. PMID: 20418023.
16. Mazloom A, Rodriguez A, Ha CS, Medeiros LJ, Wogan C, Shihadeh F, Allen P, Fowler N, Dabaja B. Incidence of gastric involvement in patients with non-gastrointestinal extranodal marginal zone lymphoma. Cancer. e-Pub 12/2010. PMID: 21157949.
17. Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, Asmar N, Munkarah AR, Ayoub CM, Shihadeh F, Berjawi G, Hannoun A, Zalloua P, Wogan C, Dabaja B. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 124(1):13-26, 11/2010. PMID: 20809361.
18. Phan J, Mazloom A, Jeffrey Medeiros L, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28(27):4170-4176, 9/2010. PMID: 20713859.
19. Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS. Marginal zone lymphomas: factors that affect the final outcome. Cancer 116(18):4291-4298, 9/2010. PMID: 20549822.
20. Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer 116(16):3825-3829, 8/2010. PMID: 20564093.
21. Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the MD Anderson Cancer Center experience. Leuk Lymphoma 51(7):1217-1224, 7/2010. PMID: 20443676.
22. Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol 28(14):2365-2372, 5/2010. PMID: 20351328.
23. Dabaja B, Perrin KJ, Romaguera JE, Horace P, Wogan CF, Shihadeh F, Salehpour MR. Successful treatment of a free-moving abdominal mass with radiation therapy guided by cone-beam computed tomography: a case report. J Med Case Reports 4:329, 2010. PMCID: PMC2974745.
24. Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD, National Comprehensive Cancer Network. Hodgkin disease/lymphoma. J Natl Compr Canc Netw 6(6):594-622, 7/2008. PMID: 18597713.
25. Geara FB, Nasr E, Tucker SL, Charafeddine M, Dabaja B, Eid T, Abbas J, Salem Z, Shamseddine A, Issa P, El Saghir N. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys 68(2):364-369, 6/2007. PMID: 17324529.
26. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. J Clin Oncol 25(1):3-5, 1/2007. PMID: 17194900.
27. Dabaja B, Salehpour MR, Rosen I, Tung S, Morrison WH, Ang KK, Garden AS. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63(4):1000-1005, 11/2005. PMID: 15978743.
28. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101(3):518-526, 8/2004. PMID: 15274064.
29. Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer 98(5):1021-1028, 9/2003. PMID: 12942571.
30. Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J 9(4):321-324, Jul-Aug, 7/2003. PMID: 12967143.
31. Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB. Uncertainties in contemporary treatment of aggressive lymphomas. Rays 28(5):289-292, Jul-Sep, 7/2003. PMID: 15018315.
32. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94(10):2738-2744, 5/2002. PMID: 12173345.
33. Dabaja BS, O'Brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 42(3):329-337, 7/2001. PMID: 11699397.
34. Taher A, Ammash Z, Dabajah B, Nasrallah A, Mourad FH. Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review. Am J Hematol 63(2):90-93, 2/2000. PMID: 10629575.
35. Shamseddine AI, Taher A, Dabaja B, Dandashi A, Salem Z, El Saghir NS. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer. Am J Clin Oncol 22(3):298-302, 6/1999. PMID: 10362341.
36. Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia 13(6):869-872, 6/1999. PMID: 10360374.
37. Taher A, Shamsseddine A, Saghir N, Seoud M, Mourad F, Dabajah B, Khalil A. Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur J Gynaecol Oncol 20(4):323-324, 1999. PMID: 10475134.

Last updated: 2/15/2013